AI assistant
Sending…
NANOVIRICIDES, INC. — Director's Dealing 2011
Aug 10, 2011
34915_dirs_2011-08-09_59765f3e-039c-40bf-b714-65951ceb43aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOVIRICIDES, INC. (NNVC.OB)
CIK: 0001379006
Period of Report: 2011-08-04
Reporting Person: Diwan Anil (Director, President, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-04 | Common Stock | S | 21900 | $1.17 | Disposed | 7466980 | Direct |
| 2011-08-05 | Common Stock | S | 22500 | $1.14 | Disposed | 7444480 | Direct |
Footnotes
F1: Does not include 33,360,000 shares of common stock held by TheraCour Pharma, Inc., of which Anil Diwan holds voting and dispositive power.
More from NANOVIRICIDES, INC.
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
May 21
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
Feb 17
Capital/Financing Update
2025
Dec 30
Regulatory Filings
2025
Dec 22
Regulatory Filings
2025
Dec 16
Capital/Financing Update
2025
Dec 15